These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 10380351

  • 21. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A, Suzuki Y, Sugihara K, Kanayama N, Urano T.
    Life Sci; 2009 Jul 31; 85(5-6):220-5. PubMed ID: 19500599
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A proteinase inhibitor from Caesalpinia echinata (pau-brasil) seeds for plasma kallikrein, plasmin and factor XIIa.
    Cruz-Silva I, Gozzo AJ, Nunes VA, Carmona AK, Faljoni-Alario A, Oliva ML, Sampaio MU, Sampaio CA, Araujo MS.
    Biol Chem; 2004 Nov 31; 385(11):1083-6. PubMed ID: 15576329
    [Abstract] [Full Text] [Related]

  • 26. Synergistic antithrombotic effect of a combination of NO donor and plasma kallikrein inhibitor.
    Ikarugi H, Inoue A, Yamashita T, Tsuda Y, Okada Y, Ishii H, Yamamoto J.
    Thromb Res; 2005 Nov 31; 116(5):403-8. PubMed ID: 16122553
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6).
    Fernández IS, Ständker L, Mägert HJ, Forssmann WG, Giménez-Gallego G, Romero A.
    J Mol Biol; 2008 Apr 11; 377(5):1488-97. PubMed ID: 18329042
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y, Stack SM, Lakka SS, Khan AJ, Woodley DT, Rao JS, Rao CN.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):112-8. PubMed ID: 10496984
    [Abstract] [Full Text] [Related]

  • 36. Development of plasmin-selective inhibitors and studies of their structure-activity relationship.
    Okada Y, Matsumoto Y, Tsuda Y, Tada M, Wanaka K, Hijikata-Okunomiya A, Okamoto S.
    Chem Pharm Bull (Tokyo); 2000 Feb 01; 48(2):184-93. PubMed ID: 10705502
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE, Nigon LV, Reid JC, de Veer SJ, Walpole CM, Stephens CR, Walsh TP, Takayama TK, Hooper JD, Clements JA, Buckle AM, Harris JM.
    Chem Biol; 2009 Jun 26; 16(6):633-43. PubMed ID: 19549601
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.